Benitec Biopharma released FY2025 Q2 earnings on February 14 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -0.2563 (forecast USD -0.7757)

Brief Summary

On February 14, 2025 (US Eastern Time), Benitec Biopharma announced its second-quarter 2025 financial results, reporting zero revenue in line with expectations, and a loss per share of -$0.2563, which significantly beat the analyst consensus estimate of -$0.7757.

Impact of The News

Analysis of Benitec Biopharma’s Q2 2025 Earnings Report